Skip to content
Mainboard BSE,NSE Bidding closed

Prostarm Info Systems IPO Subscription Status

Prostarm Info Systems IPO received bids for 1,08,86,41,296 shares against 1,12,00,000 offered, an overall subscription of 97.20x at the close of bidding (29 May 2025). NII leads at 222.14x.

Last updated · day 3 figures

Retail
39.49x
NII
222.14x
QIB
104.49x
Total
97.20x

Where the demand is

Prostarm Info Systems IPO subscription by category Each line starts at 1x (fully subscribed) and ends at the category's subscription multiple, on a logarithmic scale. Values are listed in the table below. 0.1x 1x 10x 100x 1,000x Total Total: 97.20x 97.20x QIB QIB: 104.49x 104.49x NII NII: 222.14x 222.14x bNII bNII: 249.80x 249.80x sNII sNII: 166.81x 166.81x Retail Retail: 39.49x 39.49x
Log scale. Lines run from 1x (fully subscribed): right means more demand than shares, left means shares still unbid.

Prostarm Info Systems IPO subscription by category

Category Shares offered Shares bid Amount bid Subscription
Total 1,12,00,000 1,08,86,41,296 ₹11,430.73 Cr 97.20x
QIB 32,00,000 33,43,54,194 ₹3,510.72 Cr 104.49x
NII 24,00,000 53,31,28,918 ₹5,597.85 Cr 222.14x
bNII above ₹10 lakh 16,00,000 39,96,81,294 ₹4,196.65 Cr 249.80x
sNII ₹2–10 lakh 8,00,000 13,34,47,624 ₹1,401.20 Cr 166.81x
Retail 56,00,000 22,11,58,184 ₹2,322.16 Cr 39.49x

* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.

Prostarm Info Systems IPO subscription day-wise

Category Day 3
Total 97.20x
QIB 104.49x
NII 222.14x
bNII 249.80x
sNII 166.81x
Retail 39.49x
Total added 97.20x

Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.

Prostarm Info Systems IPO reservation

Category Shares Share of issue
Qualified Institutional Buyers 32,00,000 28.57%
Non-Institutional Investors 24,00,000 21.43%
bNII · above ₹10 lakh 16,00,000 67% of NII
sNII · ₹2–10 lakh 8,00,000 33% of NII
Retail Individual Investors 56,00,000 50.00%
Public issue 1,12,00,000 100%

Allotment Chances Note

These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:

  • Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
  • Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
  • Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.

Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.

Prostarm Info Systems IPO subscription: FAQs

What is the overall subscription of Prostarm Info Systems IPO?
Prostarm Info Systems IPO is subscribed 97.20x overall as of day 3 (29 May 2025), with bids for 1,08,86,41,296 shares against 1,12,00,000 offered.
What is the retail subscription of Prostarm Info Systems IPO?
The retail portion is subscribed 39.49x as of day 3 (29 May 2025).
What is the QIB and NII subscription of Prostarm Info Systems IPO?
QIBs have subscribed 104.49x of their portion, and NIIs 222.14x (bNII 249.80x, sNII 166.81x) as of day 3 (29 May 2025).
How can I check Prostarm Info Systems IPO subscription status live?
This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
How do I apply for Prostarm Info Systems IPO?
Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 29 May 2025.

Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.